NAMS (NewAmsterdam Pharma Co NV) Buyback Yield % : -35.97 (As of Apr. 22, 2025)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

NewAmsterdam Pharma Co NV's current buyback yield was -35.97%.

NewAmsterdam Pharma Co NV Buyback Yield % Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Buyback Yield % Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

-44.65

-23.24

NewAmsterdam Pharma Co NV Quarterly Data
	Dec20	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial							-	-8.98	-11.02	-12.45	-23.24

Competitive Comparison of NewAmsterdam Pharma Co NV's Buyback Yield %

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewAmsterdam Pharma Co NV's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

NewAmsterdam Pharma Co NV Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

NewAmsterdam Pharma Co NV's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	645.507)	/	2777.2448
	=	-23.24%

NewAmsterdam Pharma Co NV's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	645.507)		/	2777.2448
	=	-23.24%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

NewAmsterdam Pharma Co NV Buyback Yield % Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.